EWING, NJ--(Marketwire - May 09, 2008) - DOR BioPharma, Inc. (OTCBB: DORB) (“DOR” or the “Company”), a late-stage biopharmaceutical company, announced today that its President and Chief Executive Officer Christopher J. Schaber, PhD, has joined the Board of Directors of the Alliance for Biosecurity, a collaboration among leading biosecurity research organizations and select biopharmaceutical companies committed to developing biodefense countermeasures to address a range of bioterrorism and natural pandemic threats.
